Probiotic therapy and functional foods for prevention of urinary tract infections: State of the art and science
- 159 Downloads
In the past year, interest has heightened in the potential for probiotics to prevent urinary tract infection (UTI). Mainly, this has been due to concerns about antibiotic resistance and recognition of the scientific efficacy of probiotics. The critical factors in any successful application of probiotics to patient care are the scientific basis for selecting probiotic strains and clinical verification that they are effective against the recurrence of UTI. Three strains—Lactobacillus rhamnosus GR-1 and Lactobacillus fermentum B-54 and RC-14—have been shown to colonize the vagina and act as a barrier to the ascension of uropathogens into the bladder. Their ability to produce growth and adhesion antagonists against urogenital pathogens is clinically important, because these appear to be important mechanisms of action. Probiotic therapy has been shown to be safe, but too few reliable products are on the market, and none are yet available for use against UTI. Given the right strains and delivery system, probiotic therapy could provide the first new UTI-prevention system in 40 years, and may help in the management of recurrent UTI.
KeywordsUrinary Tract Infection Lactobacillus Bacterial Vaginosis Glycine Betaine Vaginal Flora
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 2.Reid G: The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol 1999, 65:3763–3766. This mini-review establishes a set of scientifically based criteria upon which to select probiotic lactobacilli, and illustrates that only a handful of organisms have “passed the litmus test” of having supportive peer-reviewed publications on mechanisms of action and clinical effectiveness.PubMedGoogle Scholar
- 3.Gupta K, Scholes D, Stamm WE: Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999, 281:736–738. This confirms our findings about drug-resistant uropathogens see reference 4) and demonstrates the major increase in resistance of common uropathogens to trimethoprim-sulfamethoxazole.PubMedCrossRefGoogle Scholar
- 5.Charteris WP, Kelly PM, Morelli L, Collins JK: Antibiotic susceptibility of potentially probiotic Lactobacillus species. J Food Protection 1998, 61:1636–1643.Google Scholar
- 18.Tannock GW: The bowel microflora: an important source of urinary tract pathogens. World J Urol 1999, 17:339–344. This is an excellent perspective on the source of uropathogens, the intestine, and how different factors can influence their emergence to cause urinary tract infections (UTIs). It seems critical that we begin to understand the whole process of infection-starting at the source-rather than just focus on the virulence of pathogens on bladder and kidney epithelia. This review is part of an excellent issue of World Journal of Urology completely devoted to UTI.PubMedCrossRefGoogle Scholar
- 22.Hamilton-Miller JM, Shah S, Winkler JT: Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms. Public Health Nutr 1999, 2:223–229. This papers adds to the body of information about this subject from several other papers published during the past 10 years. The consensus is that too few probiotic products contain the material that is on the label or the viable count that is stated, and that the proof of the “healthcare” attributes or certain products are mostly unproven. The potential pathogen Enterococcus faecium was isolated from nine of 52 products studied.PubMedCrossRefGoogle Scholar